Metraipolis › archive › dc_d48c7489fe10
Anlotinib inhibits esophageal cancer malignancy by ameliorating the immune microenvironment — Europe PMC PMID:41577858
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41577858
- DOI
- 10.1007/s12672-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T13:12:06.476Z
- SHA-256 of the archived text
e00a7b58234f29682cd65d7b9db9c97716f1d458c3e73d99b83a33607c3e76ab- Stable URL of this page
https://metraipolis.com/documento/dc_d48c7489fe10
How to cite
Anlotinib inhibits esophageal cancer malignancy by ameliorating the immune microenvironment — Europe PMC PMID:41577858 — Europe PMC (en), https://europepmc.org/article/MED/41577858 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d48c7489fe10 (Metraipolis archive dc_d48c7489fe10, sha256 e00a7b58234f29682cd65d7b9db9c97716f1d458c3e73d99b83a33607c3e76ab)
BibTeX
@misc{dcd48c7489fe10,
title = {Anlotinib inhibits esophageal cancer malignancy by ameliorating the immune microenvironment — Europe PMC PMID:41577858},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41577858},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d48c7489fe10; sha256 e00a7b58234f29682cd65d7b9db9c97716f1d458c3e73d99b83a33607c3e76ab},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41577858. Agents can read the archived copy with the MCP tool read_document.